| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
33,467 |
29,147 |
$5.77M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,471 |
12,485 |
$5.47M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
32,591 |
29,331 |
$3.18M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
9,752 |
8,661 |
$1.74M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
118,027 |
91,629 |
$1.71M |
| 80053 |
Comprehensive metabolic panel |
86,113 |
71,505 |
$1.71M |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
21,132 |
16,572 |
$821K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,710 |
3,665 |
$816K |
| 84443 |
Thyroid stimulating hormone (TSH) |
25,567 |
23,266 |
$781K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
1,146 |
1,043 |
$744K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
11,521 |
7,470 |
$726K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17,632 |
11,940 |
$712K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,408 |
16,228 |
$709K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
10,675 |
8,928 |
$654K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
37,315 |
28,185 |
$653K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,788 |
8,945 |
$650K |
| 71046 |
Radiologic examination, chest; 2 views |
15,100 |
13,702 |
$648K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,190 |
1,988 |
$642K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
10,020 |
7,053 |
$611K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
6,294 |
5,752 |
$607K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
38,264 |
32,525 |
$583K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
3,517 |
3,310 |
$580K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16,258 |
14,063 |
$539K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,131 |
1,028 |
$536K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,987 |
3,688 |
$508K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20,374 |
14,566 |
$489K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
31,752 |
27,408 |
$461K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,459 |
3,103 |
$457K |
| G0378 |
Hospital observation service, per hour |
9,647 |
3,346 |
$456K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,195 |
6,405 |
$452K |
| 84484 |
|
21,895 |
16,415 |
$449K |
| 80061 |
Lipid panel |
16,442 |
15,617 |
$445K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
10,321 |
7,857 |
$444K |
| 87631 |
|
2,759 |
2,392 |
$437K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
5,696 |
4,760 |
$421K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
9,237 |
7,613 |
$421K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,323 |
1,079 |
$417K |
| 81001 |
|
33,625 |
28,884 |
$414K |
| 82248 |
|
32,821 |
27,797 |
$395K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,949 |
1,640 |
$385K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
4,044 |
2,325 |
$385K |
| 93458 |
|
359 |
305 |
$382K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13,304 |
9,611 |
$379K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
22,661 |
19,867 |
$373K |
| J9271 |
Injection, pembrolizumab, 1 mg |
130 |
92 |
$373K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
7,654 |
7,215 |
$362K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
8,073 |
7,296 |
$359K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,202 |
2,006 |
$342K |
| 83690 |
|
17,127 |
14,609 |
$319K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,634 |
4,548 |
$307K |
| 85610 |
|
22,820 |
17,511 |
$303K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,072 |
3,321 |
$302K |
| 93017 |
|
2,447 |
2,228 |
$297K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,199 |
8,090 |
$297K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,173 |
1,048 |
$293K |
| 72141 |
|
1,522 |
1,454 |
$293K |
| 88342 |
|
3,794 |
2,990 |
$290K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,855 |
1,669 |
$279K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,820 |
2,552 |
$278K |
| 81025 |
|
8,441 |
7,206 |
$278K |
| 96376 |
|
5,588 |
3,112 |
$273K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
559 |
445 |
$268K |
| 85027 |
|
14,556 |
12,386 |
$259K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,148 |
2,037 |
$243K |
| 83735 |
|
17,411 |
10,734 |
$237K |
| 59025 |
Fetal non-stress test |
2,851 |
2,072 |
$236K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
5,969 |
3,049 |
$224K |
| 97113 |
|
1,475 |
381 |
$220K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,956 |
3,385 |
$219K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,547 |
2,258 |
$215K |
| 71045 |
Radiologic examination, chest; single view |
12,574 |
10,986 |
$214K |
| 64483 |
|
594 |
535 |
$213K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,605 |
10,024 |
$207K |
| 73564 |
|
6,586 |
5,019 |
$198K |
| 72110 |
|
5,293 |
4,976 |
$198K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,732 |
1,566 |
$193K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
867 |
802 |
$188K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,114 |
2,847 |
$183K |
| 87186 |
|
10,115 |
8,778 |
$181K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
6,559 |
2,096 |
$177K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,876 |
2,609 |
$176K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
155 |
134 |
$169K |
| 77336 |
|
823 |
347 |
$167K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
793 |
742 |
$164K |
| 83605 |
|
8,999 |
7,535 |
$163K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,862 |
7,156 |
$162K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,453 |
2,547 |
$161K |
| 82607 |
|
5,850 |
5,494 |
$156K |
| 82803 |
|
6,322 |
5,229 |
$154K |
| 87077 |
|
9,185 |
8,057 |
$153K |
| 84703 |
|
6,887 |
5,969 |
$153K |
| 73221 |
|
552 |
508 |
$152K |
| 81003 |
|
9,457 |
8,490 |
$150K |
| 88304 |
|
1,403 |
1,084 |
$147K |
| 73130 |
|
4,240 |
3,255 |
$146K |
| 76770 |
|
2,282 |
2,064 |
$145K |
| 84100 |
|
12,346 |
7,687 |
$145K |
| 82728 |
|
7,155 |
6,473 |
$144K |
| 86140 |
|
14,193 |
12,602 |
$140K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,053 |
1,851 |
$135K |
| 85651 |
|
11,775 |
10,695 |
$133K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,134 |
851 |
$131K |
| 73030 |
|
5,327 |
4,513 |
$131K |
| 36591 |
|
6,090 |
3,511 |
$128K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,060 |
1,860 |
$126K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,069 |
1,016 |
$125K |
| 96417 |
|
1,403 |
765 |
$124K |
| 83880 |
|
4,728 |
4,084 |
$119K |
| 73110 |
|
3,625 |
2,896 |
$119K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,480 |
1,318 |
$114K |
| 76830 |
Ultrasound, transvaginal |
1,056 |
959 |
$111K |
| 84702 |
|
3,039 |
2,321 |
$110K |
| 85730 |
|
6,031 |
5,213 |
$109K |
| 93971 |
|
1,984 |
1,791 |
$106K |
| 76536 |
|
1,221 |
1,165 |
$105K |
| 36415 |
Collection of venous blood by venipuncture |
24,667 |
20,543 |
$104K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,272 |
2,244 |
$100K |
| 74018 |
|
3,527 |
3,153 |
$99K |
| 84439 |
|
5,037 |
4,690 |
$97K |
| 84466 |
|
5,589 |
5,137 |
$96K |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
62 |
51 |
$96K |
| 73610 |
|
3,715 |
3,134 |
$93K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,955 |
1,475 |
$91K |
| 96415 |
|
1,812 |
1,141 |
$90K |
| 87040 |
|
3,745 |
2,470 |
$90K |
| 73630 |
|
3,876 |
3,310 |
$90K |
| 86850 |
|
5,543 |
4,689 |
$89K |
| 82805 |
|
1,536 |
1,287 |
$88K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
43,963 |
33,778 |
$87K |
| 71250 |
|
1,716 |
1,584 |
$87K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,772 |
3,349 |
$85K |
| C1769 |
Guide wire |
1,217 |
1,048 |
$81K |
| 83540 |
|
6,278 |
5,758 |
$80K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
6,740 |
5,412 |
$78K |
| 74178 |
|
443 |
403 |
$76K |
| 64493 |
|
764 |
593 |
$76K |
| 97014 |
|
2,174 |
785 |
$73K |
| 77412 |
|
735 |
78 |
$72K |
| 82550 |
|
4,292 |
3,676 |
$72K |
| 73502 |
|
3,050 |
2,851 |
$71K |
| 82565 |
|
4,942 |
4,349 |
$71K |
| 86803 |
|
2,611 |
2,413 |
$70K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
540 |
511 |
$68K |
| 82378 |
|
1,353 |
832 |
$67K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,812 |
2,829 |
$66K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,524 |
1,393 |
$66K |
| 86480 |
|
830 |
782 |
$65K |
| 80050 |
General health panel |
1,603 |
1,472 |
$65K |
| 87522 |
Neg quan hep c or qual rna |
807 |
759 |
$65K |
| 20610 |
|
4,979 |
3,341 |
$65K |
| 99218 |
|
248 |
93 |
$64K |
| 86901 |
|
5,555 |
4,702 |
$64K |
| 70498 |
|
643 |
594 |
$64K |
| 87081 |
|
2,754 |
2,560 |
$63K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,701 |
1,905 |
$63K |
| 70486 |
|
570 |
539 |
$62K |
| 70496 |
|
618 |
570 |
$60K |
| 86900 |
|
5,559 |
4,707 |
$60K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,152 |
4,648 |
$60K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
958 |
670 |
$59K |
| 74019 |
|
1,374 |
1,231 |
$59K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
48 |
45 |
$59K |
| 76642 |
|
845 |
764 |
$58K |
| 74022 |
|
858 |
768 |
$57K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,243 |
1,794 |
$56K |
| 87070 |
|
3,169 |
2,656 |
$55K |
| J0875 |
Injection, dalbavancin, 5 mg |
18 |
12 |
$55K |
| 82784 |
|
2,254 |
1,610 |
$55K |
| 73562 |
|
2,212 |
1,636 |
$52K |
| 86038 |
|
1,740 |
1,611 |
$52K |
| 86235 |
|
800 |
712 |
$51K |
| 72146 |
|
266 |
256 |
$51K |
| 82570 |
|
3,996 |
3,730 |
$50K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
697 |
608 |
$49K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
4,300 |
1,875 |
$49K |
| 93880 |
|
502 |
459 |
$49K |
| 66982 |
|
85 |
63 |
$48K |
| 73522 |
|
1,881 |
1,797 |
$48K |
| 80076 |
|
2,152 |
1,954 |
$48K |
| 83516 |
|
1,668 |
1,229 |
$48K |
| 36430 |
|
213 |
151 |
$47K |
| 97161 |
|
984 |
890 |
$47K |
| 72131 |
|
496 |
450 |
$47K |
| 97162 |
|
1,072 |
993 |
$47K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,529 |
1,464 |
$46K |
| 84153 |
|
1,942 |
1,763 |
$46K |
| 86300 |
|
1,787 |
1,290 |
$46K |
| 93970 |
|
484 |
438 |
$46K |
| 87340 |
|
2,012 |
1,849 |
$46K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,452 |
2,989 |
$46K |
| 83655 |
|
2,422 |
2,309 |
$45K |
| 72158 |
|
186 |
175 |
$45K |
| 88307 |
|
340 |
234 |
$45K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
192 |
158 |
$44K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,636 |
2,191 |
$43K |
| 73620 |
|
1,492 |
1,061 |
$43K |
| 72170 |
|
1,339 |
1,262 |
$43K |
| 77066 |
Tomosynthesis, mammo |
332 |
294 |
$43K |
| 72050 |
|
948 |
880 |
$43K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
459 |
405 |
$43K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
469 |
377 |
$43K |
| 96367 |
|
2,209 |
1,458 |
$42K |
| 76801 |
|
485 |
420 |
$42K |
| 73590 |
|
1,553 |
1,313 |
$42K |
| 86706 |
|
2,018 |
1,886 |
$41K |
| 85379 |
|
2,090 |
1,857 |
$41K |
| 82043 |
|
3,006 |
2,848 |
$40K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,895 |
2,687 |
$40K |
| 64484 |
|
122 |
106 |
$40K |
| 62323 |
|
849 |
765 |
$40K |
| 82746 |
|
1,823 |
1,729 |
$39K |
| 96368 |
|
362 |
172 |
$39K |
| 96416 |
|
181 |
68 |
$38K |
| 70491 |
|
70 |
57 |
$37K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
279 |
236 |
$37K |
| 84436 |
|
794 |
720 |
$37K |
| 96411 |
|
339 |
158 |
$36K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
619 |
549 |
$36K |
| 83970 |
|
852 |
763 |
$36K |
| 87205 |
|
2,973 |
2,491 |
$36K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,459 |
1,494 |
$35K |
| 73080 |
|
1,200 |
1,028 |
$35K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
901 |
759 |
$34K |
| 73120 |
|
1,251 |
830 |
$34K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,963 |
1,725 |
$34K |
| A9578 |
Injection, gadobenate dimeglumine (multihance multipack), per ml |
2,225 |
2,037 |
$34K |
| 90715 |
|
953 |
869 |
$33K |
| 86704 |
|
1,154 |
1,073 |
$33K |
| 74183 |
|
64 |
59 |
$33K |
| 64635 |
|
394 |
303 |
$32K |
| 86160 |
|
734 |
671 |
$32K |
| 73560 |
|
884 |
778 |
$32K |
| 73090 |
|
1,012 |
839 |
$31K |
| 11045 |
|
36 |
26 |
$31K |
| 82140 |
|
1,755 |
1,448 |
$31K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
797 |
752 |
$31K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
504 |
423 |
$31K |
| 72100 |
|
986 |
904 |
$30K |
| 85007 |
|
1,422 |
1,103 |
$30K |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
1,541 |
837 |
$30K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
79 |
74 |
$29K |
| 88185 |
|
285 |
261 |
$29K |
| 83615 |
|
1,260 |
980 |
$29K |
| 86255 |
|
996 |
911 |
$28K |
| 82977 |
|
797 |
713 |
$28K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
986 |
923 |
$28K |
| 20611 |
|
1,448 |
1,122 |
$27K |
| 97597 |
|
900 |
561 |
$27K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,362 |
1,218 |
$26K |
| J8501 |
Aprepitant, oral, 5 mg |
539 |
411 |
$26K |
| 87075 |
|
1,554 |
1,300 |
$25K |
| J2704 |
Injection, propofol, 10 mg |
14,141 |
10,312 |
$25K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
72 |
62 |
$25K |
| 86200 |
|
1,013 |
927 |
$25K |
| 84460 |
|
1,080 |
906 |
$25K |
| 84156 |
|
1,453 |
1,251 |
$25K |
| 78264 |
|
113 |
106 |
$25K |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
922 |
772 |
$24K |
| 77065 |
Tomosynthesis, mammo |
264 |
224 |
$24K |
| 72052 |
|
377 |
359 |
$23K |
| 86431 |
|
1,259 |
1,166 |
$23K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
854 |
744 |
$23K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,261 |
768 |
$23K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
3,007 |
2,670 |
$23K |
| 72195 |
|
67 |
65 |
$22K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
88 |
87 |
$21K |
| 64721 |
|
64 |
52 |
$21K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
709 |
670 |
$21K |
| 84481 |
|
568 |
538 |
$21K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
158 |
146 |
$21K |
| 86376 |
|
587 |
544 |
$20K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
264 |
233 |
$20K |
| 88341 |
|
334 |
235 |
$20K |
| 84550 |
|
1,720 |
1,478 |
$20K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
142 |
107 |
$19K |
| 88300 |
|
217 |
167 |
$19K |
| 0099U |
|
23 |
17 |
$18K |
| 80164 |
|
745 |
662 |
$18K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
12 |
12 |
$18K |
| J1335 |
Injection, ertapenem sodium, 500 mg |
149 |
91 |
$18K |
| 84520 |
|
1,010 |
800 |
$18K |
| 72072 |
|
494 |
465 |
$17K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
103 |
80 |
$17K |
| 84450 |
|
882 |
721 |
$17K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,505 |
1,053 |
$17K |
| 84146 |
|
325 |
306 |
$17K |
| 78306 |
|
71 |
66 |
$17K |
| 76870 |
|
163 |
149 |
$17K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,237 |
894 |
$16K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,390 |
1,109 |
$16K |
| 86790 |
|
692 |
657 |
$16K |
| 83883 |
|
428 |
333 |
$15K |
| 86920 |
|
280 |
217 |
$15K |
| 94060 |
|
434 |
415 |
$15K |
| 87209 |
|
421 |
402 |
$15K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
5,323 |
4,386 |
$14K |
| 86618 |
|
716 |
476 |
$14K |
| 73600 |
|
314 |
288 |
$14K |
| 73060 |
|
437 |
368 |
$14K |
| 88142 |
|
642 |
572 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
365 |
330 |
$14K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
47 |
38 |
$14K |
| J1756 |
Injection, iron sucrose, 1 mg |
457 |
201 |
$13K |
| 84145 |
|
598 |
493 |
$13K |
| 87324 |
|
409 |
385 |
$13K |
| 86592 |
|
504 |
450 |
$13K |
| 73140 |
|
350 |
302 |
$13K |
| 12001 |
|
132 |
128 |
$12K |
| 93923 |
|
228 |
211 |
$12K |
| 76882 |
|
323 |
297 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,106 |
1,959 |
$12K |
| J2060 |
Injection, lorazepam, 2 mg |
987 |
719 |
$12K |
| 87210 |
|
448 |
402 |
$12K |
| 87177 |
|
421 |
402 |
$12K |
| 82247 |
|
270 |
200 |
$12K |
| 82009 |
|
208 |
168 |
$11K |
| 72040 |
|
303 |
277 |
$11K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
272 |
242 |
$11K |
| 73552 |
|
429 |
374 |
$11K |
| 84403 |
|
211 |
202 |
$10K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
407 |
295 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
172 |
121 |
$10K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
187 |
101 |
$10K |
| 86703 |
|
213 |
176 |
$10K |
| 73100 |
|
168 |
155 |
$10K |
| 72084 |
|
223 |
209 |
$10K |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
120 |
108 |
$9K |
| 97116 |
|
878 |
421 |
$9K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
796 |
632 |
$9K |
| 73070 |
|
157 |
141 |
$9K |
| 62321 |
|
51 |
50 |
$9K |
| 78227 |
|
49 |
45 |
$9K |
| 93225 |
|
195 |
189 |
$9K |
| 84165 |
|
429 |
379 |
$9K |
| 77334 |
|
38 |
30 |
$9K |
| Q3014 |
Telehealth originating site facility fee |
951 |
866 |
$9K |
| 43235 |
|
79 |
72 |
$8K |
| 93226 |
|
181 |
176 |
$8K |
| 96523 |
|
531 |
496 |
$8K |
| 88184 |
|
289 |
262 |
$8K |
| 82105 |
|
204 |
189 |
$8K |
| 86812 |
|
112 |
106 |
$8K |
| 72202 |
|
245 |
239 |
$7K |
| 77080 |
|
97 |
96 |
$7K |
| 74221 |
|
52 |
39 |
$7K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
109 |
37 |
$7K |
| 83010 |
|
92 |
80 |
$7K |
| 29580 |
|
63 |
27 |
$7K |
| G0299 |
Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes |
269 |
70 |
$7K |
| 82310 |
|
617 |
573 |
$6K |
| 87506 |
|
33 |
33 |
$6K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
252 |
79 |
$6K |
| 87045 |
|
200 |
190 |
$6K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
483 |
463 |
$6K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
221 |
195 |
$6K |
| V2632 |
Posterior chamber intraocular lens |
242 |
181 |
$6K |
| 73501 |
|
117 |
107 |
$6K |
| 12002 |
|
56 |
56 |
$6K |
| 86147 |
|
52 |
49 |
$6K |
| 87046 |
|
200 |
190 |
$6K |
| 82172 |
|
83 |
71 |
$6K |
| 86708 |
|
51 |
42 |
$6K |
| 82010 |
|
450 |
375 |
$5K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
202 |
175 |
$5K |
| 92134 |
|
559 |
499 |
$5K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
190 |
168 |
$5K |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
89 |
45 |
$5K |
| 36416 |
|
493 |
486 |
$5K |
| 10060 |
|
49 |
42 |
$5K |
| 29125 |
|
29 |
26 |
$5K |
| 88313 |
|
127 |
99 |
$5K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
243 |
201 |
$5K |
| 87493 |
|
121 |
103 |
$5K |
| 80051 |
|
462 |
432 |
$5K |
| 71101 |
|
112 |
101 |
$5K |
| 82390 |
|
129 |
123 |
$5K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
533 |
454 |
$4K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
19 |
12 |
$4K |
| A9561 |
Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries |
122 |
110 |
$4K |
| 82947 |
|
309 |
291 |
$4K |
| 82103 |
|
104 |
98 |
$4K |
| 73000 |
|
105 |
84 |
$4K |
| 90686 |
|
244 |
225 |
$4K |
| 85046 |
|
234 |
212 |
$4K |
| 72074 |
|
111 |
107 |
$4K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
51 |
46 |
$3K |
| 83993 |
|
111 |
109 |
$3K |
| 87147 |
|
165 |
154 |
$3K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
106 |
103 |
$3K |
| 69210 |
|
166 |
160 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
1,351 |
381 |
$3K |
| J1453 |
Injection, fosaprepitant, 1 mg |
132 |
83 |
$3K |
| 88173 |
|
25 |
24 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
18 |
14 |
$3K |
| 80179 |
|
133 |
118 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
222 |
200 |
$3K |
| 82150 |
|
47 |
43 |
$3K |
| 94729 |
|
220 |
209 |
$3K |
| C1755 |
Catheter, intraspinal |
2,529 |
2,070 |
$3K |
| 86334 |
|
74 |
65 |
$3K |
| 97035 |
|
51 |
12 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,722 |
1,058 |
$3K |
| 77417 |
|
28 |
14 |
$3K |
| J9045 |
Injection, carboplatin, 50 mg |
153 |
92 |
$3K |
| 87641 |
|
107 |
104 |
$3K |
| 93308 |
|
89 |
82 |
$2K |
| 84478 |
|
82 |
62 |
$2K |
| 81015 |
|
27 |
24 |
$2K |
| 80055 |
|
67 |
61 |
$2K |
| 82951 |
|
40 |
36 |
$2K |
| 77061 |
|
26 |
24 |
$2K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
166 |
139 |
$2K |
| 83521 |
|
229 |
196 |
$2K |
| 92567 |
|
448 |
421 |
$2K |
| 82952 |
|
40 |
36 |
$2K |
| 86665 |
|
44 |
28 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
194 |
176 |
$2K |
| 51798 |
|
1,465 |
1,207 |
$2K |
| 80069 |
|
845 |
599 |
$2K |
| 87481 |
|
12 |
12 |
$2K |
| 94726 |
|
160 |
152 |
$2K |
| 86308 |
|
84 |
76 |
$2K |
| 94660 |
|
52 |
25 |
$2K |
| J1940 |
Injection, furosemide, up to 20 mg |
425 |
258 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,264 |
5,036 |
$2K |
| 74021 |
|
76 |
66 |
$2K |
| J3490 |
Unclassified drugs |
10,670 |
3,316 |
$2K |
| 83001 |
|
30 |
28 |
$1K |
| 71271 |
|
34 |
26 |
$1K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
14 |
13 |
$1K |
| 92557 |
|
129 |
120 |
$1K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
19 |
12 |
$1K |
| 81206 |
|
13 |
13 |
$1K |
| 87106 |
|
29 |
26 |
$1K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
156 |
131 |
$1K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
367 |
264 |
$1K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
339 |
157 |
$1K |
| 89051 |
|
41 |
26 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
12 |
12 |
$1K |
| 87338 |
|
46 |
44 |
$1K |
| 96377 |
|
19 |
12 |
$1K |
| 76942 |
|
152 |
102 |
$1K |
| 84132 |
|
103 |
97 |
$1K |
| 86762 |
|
18 |
12 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
45 |
44 |
$1K |
| 86664 |
|
29 |
28 |
$1K |
| G0379 |
Direct admission of patient for hospital observation care |
41 |
31 |
$980.41 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
551 |
468 |
$926.26 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
200 |
133 |
$864.48 |
| 12011 |
|
13 |
12 |
$842.00 |
| 75635 |
|
16 |
13 |
$811.14 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
16 |
12 |
$785.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
142 |
136 |
$755.79 |
| 87176 |
|
35 |
30 |
$684.69 |
| 92587 |
|
12 |
12 |
$659.85 |
| 86617 |
|
24 |
24 |
$645.63 |
| 86709 |
|
13 |
12 |
$631.87 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
12 |
12 |
$624.47 |
| 88112 |
|
50 |
44 |
$609.04 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
730 |
549 |
$588.31 |
| 97535 |
Self-care/home management training, each 15 minutes |
300 |
195 |
$529.68 |
| 86364 |
|
57 |
51 |
$491.08 |
| 84480 |
|
16 |
15 |
$483.15 |
| 74230 |
|
12 |
12 |
$478.25 |
| 86341 |
|
15 |
12 |
$422.24 |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
16 |
12 |
$409.64 |
| 51702 |
|
231 |
188 |
$388.46 |
| 87076 |
|
46 |
38 |
$384.63 |
| 72192 |
|
13 |
12 |
$378.12 |
| 74250 |
|
18 |
18 |
$373.42 |
| 87015 |
|
89 |
69 |
$372.54 |
| 87329 |
|
26 |
26 |
$360.97 |
| 86705 |
|
16 |
15 |
$358.45 |
| 74220 |
|
12 |
12 |
$339.78 |
| 84402 |
|
15 |
15 |
$335.74 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
505 |
288 |
$280.18 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
52 |
32 |
$279.65 |
| 74420 |
|
18 |
13 |
$259.38 |
| 83520 |
|
17 |
17 |
$245.13 |
| 90656 |
|
38 |
37 |
$239.04 |
| 84681 |
|
14 |
12 |
$235.41 |
| 92136 |
|
60 |
57 |
$231.28 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
15 |
13 |
$222.63 |
| 97016 |
|
27 |
12 |
$201.34 |
| J3480 |
Injection, potassium chloride, per 2 meq |
68 |
26 |
$178.10 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
213 |
165 |
$152.48 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
552 |
479 |
$144.48 |
| 94760 |
|
684 |
275 |
$143.30 |
| J3411 |
Injection, thiamine hcl, 100 mg |
40 |
31 |
$134.53 |
| 72070 |
|
14 |
13 |
$129.42 |
| 90653 |
|
26 |
26 |
$119.71 |
| 93242 |
|
37 |
36 |
$115.89 |
| G0008 |
Administration of influenza virus vaccine |
14 |
14 |
$95.84 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
32 |
30 |
$85.96 |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
15 |
13 |
$65.15 |
| 86780 |
|
12 |
12 |
$61.20 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
263 |
243 |
$56.30 |
| 90694 |
|
17 |
15 |
$37.75 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
1,335 |
1,004 |
$35.41 |
| 82077 |
|
286 |
241 |
$34.88 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
20 |
14 |
$31.40 |
| 85018 |
|
14 |
13 |
$26.58 |
| 82962 |
|
40 |
35 |
$14.75 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
56 |
49 |
$13.89 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
104 |
85 |
$13.43 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
83 |
57 |
$8.06 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
44 |
25 |
$7.11 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
23 |
15 |
$6.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
13 |
12 |
$5.17 |
| Q9960 |
High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml |
290 |
263 |
$2.72 |
| C9113 |
Injection, pantoprazole sodium, per vial |
104 |
36 |
$0.39 |
| C1760 |
Closure device, vascular (implantable/insertable) |
15 |
15 |
$0.00 |
| C9257 |
Injection, bevacizumab, 0.25 mg |
16 |
12 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
19 |
12 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
31 |
30 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
40 |
26 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
257 |
244 |
$0.00 |
| Q0240 |
Injection, casirivimab and imdevimab, 600 mg |
74 |
34 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
12 |
12 |
$0.00 |